340 filings
Page 5 of 17
8-K
bvmhdb 5uadhwaqap6
27 Jan 22
Zymeworks Announces Proposed Public Offering
5:00pm
424B5
sni38e9ast7 er50h9y
27 Jan 22
Prospectus supplement for primary offering
4:56pm
424B5
mibh6mtwgdvd hatd
26 Jan 22
Prospectus supplement for primary offering
4:26pm
8-K
uq4ba07l98 5yrjqc4
19 Jan 22
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2022
4:51pm
8-K
d65 ymznq
18 Jan 22
Zymeworks Reports Inducement Grant Under New York Stock Exchange Listed Company Manual Rule
6:19am
8-K
5g2bulx420l6l
6 Jan 22
Zymeworks to Present at 40th Annual J.P. Morgan Healthcare Conference
4:15pm
8-K
tnf6buo 10p3rvxs
5 Jan 22
Zymeworks Names Biotechnology Industry Leader Kenneth Galbraith as Chair and CEO to Succeed Dr. Ali Tehrani
5:11pm
8-K
sf0z827gy479zt3
9 Dec 21
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in Asia in Collaboration with BeiGene and Associated Milestone Payment
4:16pm
8-K
sqr 8ok6op
9 Dec 21
Zanidatamab Data Presented at the San Antonio Breast Cancer Symposium
12:00am
8-K
e8oegv1t147aut7
1 Dec 21
Zymeworks Announces Second Janssen Bispecific Antibody to Begin Clinical Development Utilizing Azymetric™ and EFECT™ Therapeutic Platforms
4:16pm
8-K
6kcvn0ug10b9kb7cvo3i
19 Nov 21
Zymeworks Announces Abstract for Zanidatamab in Late-Line HER2-Positive
4:33pm
8-K
w2e0x4a yj6oa
9 Nov 21
Zymeworks Launches Global Phase 3 Zanidatamab Trial in First-Line
5:05pm
8-K
4uhg 37x4h28x6wyvb
8 Nov 21
Zymeworks to Present at Upcoming Investor Conferences
5:01pm
8-K
dk8pba
3 Nov 21
Zymeworks Reports 2021 Third Quarter Financial Results
4:19pm
8-K
w4vcvat5vdun3v4tji
26 Oct 21
Zymeworks Announces Webcast to Present HERIZON-GEA-01 Pivotal Trial Design and Zanidatamab Commercial Strategy in Gastrointestinal Cancers
4:16pm
8-K
9ekzy2hrr3q
5 Oct 21
Regulation FD Disclosure
4:06pm
8-K
gwcs 6j79whw2
1 Oct 21
Entry into a Material Definitive Agreement
5:25pm
424B5
09hlvgtu4ssfnfu
1 Oct 21
Prospectus supplement for primary offering
5:10pm
S-3ASR
j4ob97s75 dch
1 Oct 21
Automatic shelf registration
4:45pm